FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Beverly Teicher

Research Profile

Living Beings

Anatomy

Tumor Cells, Cultured

Physiology

Chemicals & Drugs

Disorders

Procedures

Co-author Network

Publications

TOP 3
Tri-Hung Nguyen; Bruce Roberts; Beverly A Teicher; William Weber; Rebecca G Bagley; Timothy Connors; Evis Havari; Johanne Kaplan; Stephen L Madden; Rajashree McLaren; Prashant R Nambiar; Srinivas Shankara
Expression of TMPRSS4 in non-small cell lung cancer and its modulation by hypoxia.
Lilly Chai; Rajashree P McLaren; Ann Byrne; Wei-Lien Chuang; Yinyin Huang; Michael R Dufault; Joshua Pacheco; Shruti Madhiwalla; Xiaokui Zhang; Mindy Zhang; Beverly A Teicher; Kara Carter; Seng H Cheng; John P Leonard; Yibin Xiang; Michael Vasconcelles; Mark A Goldberg; Diane P Copeland; Katherine W Klinger; James Lillie; Stephen L Madden; Yide A Jiang
The chemosensitizing activity of inhibitors of glucosylceramide synthase is mediated primarily through modulation of P-gp function.
Qiang Zhang; Lihua J Zhu; Scott Lonning; Vidit Sharma; Beverly A Teicher; Ximing J Yang; Nengwang Yu; Charles Brendler; William J Catalona; Lin Chen; Yinglu Guo; Jay Harper; Brian T Helfand; Thomas L Jang; Borko Javonovic; James Kozlowski; Timothy Michael Kuzel; Chung Lee
TGF-β regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrence.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Beverly Teicher (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Tri-Hung Nguyen; Bruce Roberts; Beverly A Teicher; William Weber; Rebecca G Bagley; Timothy Connors; Evis Havari; Johanne Kaplan; Stephen L Madden; Rajashree McLaren; Prashant R Nambiar; Srinivas Shankara
Expression of TMPRSS4 in non-small cell lung cancer and its modulation by hypoxia.
International journal of oncology 2012;41(3):829-38.
2011: Lilly Chai; Rajashree P McLaren; Ann Byrne; Wei-Lien Chuang; Yinyin Huang; Michael R Dufault; Joshua Pacheco; Shruti Madhiwalla; Xiaokui Zhang; Mindy Zhang; Beverly A Teicher; Kara Carter; Seng H Cheng; John P Leonard; Yibin Xiang; Michael Vasconcelles; Mark A Goldberg; Diane P Copeland; Katherine W Klinger; James Lillie; Stephen L Madden; Yide A Jiang
The chemosensitizing activity of inhibitors of glucosylceramide synthase is mediated primarily through modulation of P-gp function.
International journal of oncology 2011;38(3):701-11.
2011: Qiang Zhang; Lihua J Zhu; Scott Lonning; Vidit Sharma; Beverly A Teicher; Ximing J Yang; Nengwang Yu; Charles Brendler; William J Catalona; Lin Chen; Yinglu Guo; Jay Harper; Brian T Helfand; Thomas L Jang; Borko Javonovic; James Kozlowski; Timothy Michael Kuzel; Chung Lee
TGF-β regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrence.
PloS one 2011;6(9):e25168.
2011: Beverly A Teicher
Antiangiogenic agents and targets: A perspective.
Biochemical pharmacology 2011;81(1):6-12.
2010: Beverly A Teicher
Combinations of PARP, hedgehog and HDAC inhibitors with standard drugs.
Current opinion in pharmacology 2010;10(4):397-404.
2010: Ann Byrne; Rajashree P McLaren; Paul Mason; Lilly Chai; Michael R Dufault; Yinyin Huang; Beirong Liang; Joseph D Gans; Mindy Zhang; Kara Carter; Tatiana B Gladysheva; Beverly A Teicher; Hans-Peter N Biemann; Michael Booker; Mark A Goldberg; Katherine W Klinger; James Lillie; Stephen L Madden; Yide Jiang
Knockdown of human deubiquitinase PSMD14 induces cell cycle arrest and senescence.
Experimental cell research 2010;316(2):258-71.
2009: Beverly A Teicher
Human tumor xenografts and mouse models of human tumors: re-discovering the models.
Expert opinion on drug discovery 2009;4(12):1295-305.
2009: Leslie S Kurtzberg; Stephanie D Roth; Rebecca G Bagley; Cecile Rouleau; Min Yao; Jennifer L Crawford; Roy D Krumbholz; Steven M Schmid; Beverly A Teicher
Bone marrow CFU-GM and human tumor xenograft efficacy of three tubulin binding agents.
Cancer chemotherapy and pharmacology 2009;64(5):1029-38.
2009: Beverly A Teicher
Acute and chronic in vivo therapeutic resistance.
Biochemical pharmacology 2009;77(11):1665-73.
2009: Rebecca G Bagley; Stephanie Roth; Leslie S Kurtzberg; Cecile Rouleau; Min Yao; Jennifer Crawford; Roy Krumbholz; Dennis Lovett; Steven Schmid; Beverly A Teicher
Bone marrow CFU-GM and human tumor xenograft efficacy of three antitumor nucleoside analogs.
International journal of oncology 2009;34(5):1329-40.
2009: Mariana Nacht; Thia B St Martin; Ann Byrne; Katherine W Klinger; Beverly A Teicher; Stephen L Madden; Yide Jiang
Netrin-4 regulates angiogenic responses and tumor cell growth.
Experimental cell research 2009;315(5):784-94.
2009: Rebecca G Bagley; William Weber; Cecile Rouleau; Min Yao; Nakayuki Honma; Shiro Kataoka; Isao Ishida; Bruce L Roberts; Beverly A Teicher
Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers.
International journal of oncology 2009;34(3):619-27.
2009: Beverly A Teicher
In vivo/ex vivo and in situ assays used in cancer research: a brief review.
Toxicologic pathology 2009;37(1):114-22.
2008: Cecile Rouleau; Maritza Curiel; William Weber; Robert Smale; Leslie Kurtzberg; James Mascarello; Carol Berger; Gina Wallar; Rebecca Bagley; Nakayuki Honma; Kazumasa Hasegawa; Isao Ishida; Shiro Kataoka; Beth L Thurberg; Khodadad Mehraein; Bruce Horten; Glenn Miller; Beverly A Teicher
Endosialin protein expression and therapeutic target potential in human solid tumors: sarcoma versus carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(22):7223-36.
2008: Rebecca G Bagley; Nakayuki Honma; William Weber; Paula Boutin; Cecile Rouleau; Srinivas Shankara; Shiro Kataoka; Isao Ishida; Bruce L Roberts; Beverly A Teicher
Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization.
Microvascular research 2008;76(3):180-8.
2008: Leslie S Kurtzberg; Traci Battle; Cecile Rouleau; Rebecca G Bagley; Naoki Agata; Min Yao; Steven Schmid; Stephanie Roth; Jennifer Crawford; Roy Krumbholz; Reginald Ewesuedo; Xian-Jie Yu; Fei Wang; Edmond J Lavoie; Beverly A Teicher
Bone marrow and tumor cell colony-forming units and human tumor xenograft efficacy of noncamptothecin and camptothecin topoisomerase I inhibitors.
Molecular cancer therapeutics 2008;7(10):3212-22.
2008: Rebecca G Bagley; Cecile Rouleau; Thia St Martin; Paula Boutin; William Weber; Melanie Ruzek; Nakayuki Honma; Mariana Nacht; Srinivas Shankara; Shiro Kataoka; Isao Ishida; Bruce L Roberts; Beverly A Teicher
Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248.
Molecular cancer therapeutics 2008;7(8):2536-46.
2008: Kent Perry; Larry Wong; Victoria Liu; Irwin Park; Qiang Zhang; Varun Rejen; Xuemei Huang; Norm D Smith; Borko Jovanovic; Scott Lonning; Beverly A Teicher; Chung Lee
Treatment of transforming growth factor-beta-insensitive mouse Renca tumor by transforming growth factor-beta elimination.
Urology 2008;72(1):225-9.
2008: Cecile Rouleau; Krishna Menon; Paula Boutin; Cheryl Guyre; Hitoshi Yoshida; Shiro Kataoka; Michael Perricone; Srinivas Shankara; Arthur E Frankel; Nicholas S Duesbery; George Vande Woude; Hans-Peter Biemann; Beverly A Teicher
The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution.
International journal of oncology 2008;32(4):739-48.
2008: Beverly A Teicher
Newer cytotoxic agents: attacking cancer broadly.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(6):1610-7.
2008: Beverly A Teicher
Next generation topoisomerase I inhibitors: Rationale and biomarker strategies.
Biochemical pharmacology 2008;75(6):1262-71.
2004: Karen L Lobb; Philip A Hipskind; James A Aikins; Enrique Alvarez; Yiu-Yin Cheung; Eileen L Considine; Alfonso de Dios; Gregory L Durst; Rafael Ferritto; Cora Sue Grossman; Deborah D Giera; Beth A Hollister; Zhongping Huang; Philip W Iversen; Kevin L Law; Tiechao Li; Ho-Shen Lin; Beatriz Lopez; Jose E Lopez; Luisa M Martin Cabrejas; Denis J McCann; Victoriano Molero; John E Reilly; Michael E Richett; Chuan Shih; Beverly A Teicher; James H Wikel; Wesley T White; Mary M Mader
Acyl sulfonamide anti-proliferatives: benzene substituent structure-activity relationships for a novel class of antitumor agents.
Journal of medicinal chemistry 2004;47(22):5367-80.
2004: Kristan A Keyes; Larry Mann; Michael Sherman; Elizabeth Galbreath; Linda Schirtzinger; Darryl Ballard; Yun-Fei Chen; Philip Iversen; Beverly A Teicher
LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing mice.
Cancer chemotherapy and pharmacology 2004;53(2):133-40.
2003: Enrique Alvarez; Michael Westmore; Rachelle J Sells Galvin; Crystal L Clapp; Eileen L Considine; Shawn J Smith; Kristan A Keyes; Philip W Iversen; Dawn M Delafuente; Shola Sulaimon; Carmen Zambrano; Linda Ma; Masahiko Sato; T John Martin; Beverly A Teicher; Elizabeth Galbreath
Properties of bisphosphonates in the 13762 rat mammary carcinoma model of tumor-induced bone resorption.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(15):5705-13.
2003: Guoxin Zhu; Scott E Conner; Xun Zhou; Chuan Shih; Tiechao Li; Bryan D Anderson; Harold B Brooks; Robert M Campbell; Eileen L Considine; Jack A Dempsey; Margaret M Faul; Catherine A Ogg; Bharvin Patel; Richard M Schultz; Charles D Spencer; Beverly A Teicher; Scott A Watkins
Synthesis, structure-activity relationship, and biological studies of indolocarbazoles as potent cyclin D1-CDK4 inhibitors.
Journal of medicinal chemistry 2003;46(11):2027-30.
2003: Guoxin Zhu; Scott E Conner; Xun Zhou; Chuan Shih; Harold B Brooks; Eileen L Considine; Jack A Dempsey; Catherine A Ogg; Bharvin Patel; Richard M Schultz; Charles D Spencer; Beverly A Teicher; Scott A Watkins
Synthesis of quinolinyl/isoquinolinyl[a]pyrrolo [3,4-c] carbazoles as cyclin D1/CDK4 inhibitors.
Bioorganic & medicinal chemistry letters 2003;13(7):1231-5.
2003: Kristan A Keyes; Larry Mann; Karen Cox; Patti Treadway; Philip Iversen; Yun-Fei Chen; Beverly A Teicher
Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex Multiplex technology.
Cancer chemotherapy and pharmacology 2003;51(4):321-7.
2003: Kristan A Keyes; Larry Mann; Beverly A Teicher; Enrique Alvarez
Site-dependent angiogenic cytokine production in human tumor xenografts.
Cytokine 2003;21(2):98-104.
2002: Kristan A Keyes; Karen Cox; Patti Treadway; Larry Mann; Chuan Shih; Margaret M Faul; Beverly A Teicher
An in vitro tumor model: analysis of angiogenic factor expression after chemotherapy.
Cancer research 2002;62(19):5597-602.
2002: Beverly A Teicher; Krishna Menon; Enrique Alvarez; Chuan Shih; Margaret M Faul
Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human breast cancer and ovarian cancer xenografts.
Investigational new drugs 2002;20(3):241-51.
2002: Beverly A Teicher; Enrique Alvarez; Krishna Menon; Michail A Esterman; Eileen L Considine; Chuan Shih; Margaret M Faul
Antiangiogenic effects of a protein kinase Cbeta-selective small molecule.
Cancer chemotherapy and pharmacology 2002;49(1):69-77.
2001: Beverly A Teicher; Krishna Menon; Enrique Alvarez; Elizabeth Galbreath; Chuan Shih; Margaret M Faul
Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in murine lewis lung carcinoma and human Calu-6 non-small-cell lung carcinoma xenografts.
Cancer chemotherapy and pharmacology 2001;48(6):473-80.
2001: Beverly A Teicher; Krishna Menon; Enrique Alvarez; Elizabeth Galbreath; Chuan Shih; Margaret M Faul
Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human HT-29 colon carcinoma and human CaKi1 renal cell carcinoma xenografts.
Anticancer research 2001;21(5):3175-84.
2001: Alexzander Asea; R Mallick; Stanislav Lechpammer; G Ara; Beverly A Teicher; Susana Fiorentino; Mary Ann Stevenson; Stuart K Calderwood
Cyclooxygenase inhibitors are potent sensitizers of prostate tumours to hyperthermia and radiation.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2001;17(5):401-14.
2001: Chuan Shih; Beverly A Teicher
Cryptophycins: a novel class of potent antimitotic antitumor depsipeptides.
Current pharmaceutical design 2001;7(13):1259-76.
2001: Alexzander Asea; G Ara; Beverly A Teicher; Mary Ann Stevenson; Stuart K Calderwood
Effects of the flavonoid drug quercetin on the response of human prostate tumours to hyperthermia in vitro and in vivo.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2001;17(4):347-56.
2001: Beverly A Teicher; Krishna Menon; Enrique Alvarez; P Liu; Chuan Shih; Margaret M Faul
Antiangiogenic and antitumor effects of a protein kinase C beta inhibitor in human hepatocellular and gastric cancer xenografts.
In vivo (Athens, Greece) 2001;15(3):185-93.
2001: Beverly A Teicher; Krishna Menon; Enrique Alvarez; Elizabeth Galbreath; Chuan Shih; Margaret M Faul
Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human T98G glioblastoma multiforme xenografts.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3):634-40.
2001: K Lu; Jack Dempsey; Richard M Schultz; Chuan Shih; Beverly A Teicher
Cryptophycin-induced hyperphosphorylation of Bcl-2, cell cycle arrest and growth inhibition in human H460 NSCLC cells.
Cancer chemotherapy and pharmacology 2001;47(2):170-8.
2000: Beverly A Teicher; PA Forler; Krishna Menon; VG Phares; T Amsrud; Chuan Shih
Cryptophycin 52 and cryptophycin 55 in sequential and simultaneous combination treatment regimens in human tumor xenografts.
In vivo (Athens, Greece) 2000;14(4):471-80.
2000: Beverly A Teicher; V Chen; Chuan Shih; Krishna Menon; PA Forler; VG Phares; T Amsrud
Treatment regimens including the multitargeted antifolate LY231514 in human tumor xenografts.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(3):1016-23.
2000: P Liu; Krishna Menon; Enrique Alvarez; K Lu; Beverly A Teicher
Transforming growth factor-beta and response to anticancer therapies in human liver and gastric tumors in vitro and in vivo.
International journal of oncology 2000;16(3):599-610.
2000: K Lu; Chuan Shih; Beverly A Teicher
Expression of pRB, cyclin/cyclin-dependent kinases and E2F1/DP-1 in human tumor lines in cell culture and in xenograft tissues and response to cell cycle agents.
Cancer chemotherapy and pharmacology 2000;46(4):293-304.
2000: Krishna Menon; Enrique Alvarez; PA Forler; VG Phares; T Amsrud; Chuan Shih; Rima S Al-Awar; Beverly A Teicher
Antitumor activity of cryptophycins: effect of infusion time and combination studies.
Cancer chemotherapy and pharmacology 2000;46(2):142-9.
2000: Emil Frei; G Ara; Beverly A Teicher; Craig A Bunnell; Paul Richardson; C Wheeler; K Tew; A Elias
Double high-dose chemotherapy with stem cell rescue (HD-SCR) in patients with breast cancer - effect of sequence.
Cancer chemotherapy and pharmacology 2000;45(3):239-46.
1999: Beverly A Teicher; G Ara; R Herbst; Vito J Palombella; Julian Adams
The proteasome inhibitor PS-341 in cancer therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(9):2638-45.
1999: Beverly A Teicher; Enrique Alvarez; P Liu; K Lu; Krishna Menon; Jack Dempsey; Richard M Schultz
MTA (LY231514) in combination treatment regimens using human tumor xenografts and the EMT-6 murine mammary carcinoma.
Seminars in oncology 1999;26(2 Suppl 6):55-62.
1999: Beverly A Teicher; Enrique Alvarez; LG Mendelsohn; G Ara; Krishna Menon; D K Ways
Enzymatic rationale and preclinical support for a potent protein kinase C beta inhibitor in cancer therapy.
Advances in enzyme regulation 1999;39():313-27.
1998: Beverly A Teicher; G Ara; Y N Chen; A Recht; C Norman Coleman
Interaction of tomudex with radiation in vitro and in vivo.
International journal of oncology 1998;13(3):437-42.
1998: Beverly A Teicher; J I Williams; H Takeuchi; G Ara; Roy S Herbst; D Buxton
Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma.
Anticancer research 1998;18(4A):2567-73.
1998: Anthony D Elias; C Wheeler; Lois Jeanne Ayash; Gary Schwartz; Joseph G Ibrahim; L Mills; Mary McCauley; C Norman Coleman; Diane Warren; Lowell E Schnipper; Karen Antman; Beverly A Teicher; Emil Frei
Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(6):1443-9.
1998: G Ara; LM Gravelin; R Kaddurah-Daouk; Beverly A Teicher
Antitumor activity of creatine analogs produced by alterations in pancreatic hormones and glucose metabolism.
In vivo (Athens, Greece) 1998;12(2):223-31.
1998: Beverly A Teicher; G Ara; SR Keyes; Roy S Herbst; Emil Frei
Acute in vivo resistance in high-dose therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(2):483-91.
1998: H Takeuchi; G Ara; Edward A Sausville; Beverly A Teicher
Jasplakinolide: interaction with radiation and hyperthermia in human prostate carcinoma and Lewis lung carcinoma.
Cancer chemotherapy and pharmacology 1998;42(6):491-6.
1998: Joseph P Eder; V Chan; Julia S Wong; Y W Wong; G Ara; D Northey; N Rizvi; Beverly A Teicher
Sequence effect of irinotecan (CPT-11) and topoisomerase II inhibitors in vivo.
Cancer chemotherapy and pharmacology 1998;42(4):327-35.
1998: Beverly A Teicher; Julia S Wong; H Takeuchi; LM Gravelin; G Ara; D Buxton
Allosteric effectors of hemoglobin as modulators of chemotherapy and radiation therapy in vitro and in vivo.
Cancer chemotherapy and pharmacology 1998;42(1):24-30.
1998: Beverly A Teicher; G Ara; D Buxton; J Leonard; R G Schaub
Optimal scheduling of interleukin-12 and fractionated radiation therapy in the murine Lewis lung carcinoma.
Radiation oncology investigations 1998;6(2):71-80.
1998: Roy S Herbst; H Takeuchi; Beverly A Teicher
Paclitaxel/carboplatin administration along with antiangiogenic therapy in non-small-cell lung and breast carcinoma models.
Cancer chemotherapy and pharmacology 1998;41(6):497-504.
1997: Beverly A Teicher; M Ikebe; G Ara; SR Keyes; Roy S Herbst
Transforming growth factor-beta 1 overexpression produces drug resistance in vivo: reversal by decorin.
In vivo (Athens, Greece) 1997;11(6):463-72.
1997: Beverly A Teicher; Y Kakeji; G Ara; Roy S Herbst; D Northey
Prostate carcinoma response to cytotoxic therapy: in vivo resistance.
In vivo (Athens, Greece) 1997;11(6):453-61.
1997: Beverly A Teicher; G Ara; D Buxton; J Leonard; R G Schaub
Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(9):1661-7.
1997: Beverly A Teicher; G Ara; R Herbst; H Takeuchi; SR Keyes; D Northey
PEG-hemoglobin: effects on tumor oxygenation and response to chemotherapy.
In vivo (Athens, Greece) 1997;11(4):301-11.
1997: Beverly A Teicher; Y Maehara; Y Kakeji; G Ara; SR Keyes; Julia S Wong; R Herbst
Reversal of in vivo drug resistance by the transforming growth factor-beta inhibitor decorin.
International journal of cancer. Journal international du cancer 1997;71(1):49-58.
1997: Y Kakeji; Y Maehara; M Ikebe; Beverly A Teicher
Dynamics of tumor oxygenation, CD31 staining and transforming growth factor-beta levels after treatment with radiation or cyclophosphamide in the rat 13762 mammary carcinoma.
International journal of radiation oncology, biology, physics 1997;37(5):1115-23.
1997: Y Kakeji; Beverly A Teicher
Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents.
Investigational new drugs 1997;15(1):39-48.
1997: S A Holden; Y Emi; Y Kakeji; D Northey; Beverly A Teicher
Host distribution and response to antitumor alkylating agents of EMT-6 tumor cells from subcutaneous tumor implants.
Cancer chemotherapy and pharmacology 1997;40(1):87-93.
1996: Beverly A Teicher; Y Emi; Y Kakeji; D Northey
TNP-470/minocycline/cytotoxic therapy: a systems approach to cancer therapy.
European journal of cancer (Oxford, England : 1990) 1996;32A(14):2461-6.
1996: Lois Jeanne Ayash; A Elias; Gary Schwartz; C Wheeler; Joseph G Ibrahim; Beverly A Teicher; E Reich; Diane Warren; C Lynch; Paul Richardson; Lowell E Schnipper; Emil Frei; Karen Antman
Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(11):2984-92.
1996: Beverly A Teicher; Y N Chen; G Ara; Y Emi; Y Kakeji; Y Maehara; SR Keyes; D Northey
Interaction of interleukin-11 with cytotoxic therapies in vitro against CEM cells and in vivo against EMT-6 murine mammary carcinoma.
International journal of cancer. Journal international du cancer 1996;67(6):864-70.
1996: Beverly A Teicher; D Northey; J Yuan; Emil Frei
High-dose therapy/stem cell support: comparison of mice and humans.
International journal of cancer. Journal international du cancer 1996;65(5):695-9.
1996: Beverly A Teicher; G Ara; Krishna Menon; R G Schaub
In vivo studies with interleukin-12 alone and in combination with monocyte colony-stimulating factor and/or fractionated radiation treatment.
International journal of cancer. Journal international du cancer 1996;65(1):80-4.
1996: Julia S Wong; G Ara; SR Keyes; Roy S Herbst; C Norman Coleman; Beverly A Teicher
Lisofylline as a modifier of radiation therapy.
Oncology research 1996;8(12):513-8.
1996: G Ara; Beverly A Teicher
Cyclooxygenase and lipoxygenase inhibitors in cancer therapy.
Prostaglandins, leukotrienes, and essential fatty acids 1996;54(1):3-16.
1996: Beverly A Teicher; S A Holden; D A Goff; J E Wright; O Tretyakov; Lois Jeanne Ayash
Antitumor efficacy and pharmacokinetic analysis of 4-hydroperoxycyclophosphamide in comparison with cyclophosphamide +/- hepatic enzyme effectors.
Cancer chemotherapy and pharmacology 1996;38(6):553-60.
1996: Beverly A Teicher; S A Holden; G Ara; T Korbut; Krishna Menon
Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma.
Cancer chemotherapy and pharmacology 1996;38(2):169-77.
1996: Beverly A Teicher; S A Holden; G Ara; G Chen
Transforming growth factor-beta in in vivo resistance.
Cancer chemotherapy and pharmacology 1996;37(6):601-9.
1996: G H Zhou; Beverly A Teicher; E Frei
Postlabeling detection of DNA adducts of antitumor alkylating agents.
Cancer chemotherapy and pharmacology 1996;38(1):71-80.
1995: Joseph P Eder; V T Chan; S W Ng; N A Rizvi; S Zacharoulis; Beverly A Teicher; Lowell E Schnipper
DNA topoisomerase II alpha expression is associated with alkylating agent resistance.
Cancer research 1995;55(24):6109-16.
1995: Beverly A Teicher; S A Holden; G Ara; Krishna Menon
Whole-body hyperthermia and lonidamine as adjuvant therapy to treatment with cisplatin with or without local radiation in mouse bearing the Lewis lung carcinoma.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1995;11(5):637-45.
1995: T Kusumoto; S A Holden; G Ara; Beverly A Teicher
Hyperthermia and platinum complexes: time between treatments and synergy in vitro and in vivo.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1995;11(4):575-86.
1995: Beverly A Teicher; S A Holden; G Ara; N P Dupuis; F Liu; J Yuan; M Ikebe; Y Kakeji
Influence of an anti-angiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy.
International journal of cancer. Journal international du cancer 1995;61(5):732-7.
1995: Beverly A Teicher; S A Holden; G Ara; N P Dupuis; D Goff
Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
The cancer journal from Scientific American 1995;1(1):43-8.
1995: Beverly A Teicher
Physiologic mechanisms of therapeutic resistance. Blood flow and hypoxia.
Hematology/oncology clinics of North America 1995;9(2):475-506.
1995: Beverly A Teicher; N P Dupuis; M F Robinson; Y Emi; D A Goff
Antiangiogenic treatment (TNP-470/minocycline) increases tissue levels of anticancer drugs in mice bearing Lewis lung carcinoma.
Oncology research 1995;7(5):237-43.
1995: Beverly A Teicher; S A Holden; N P Dupuis; Y Kakeji; M Ikebe; Y Emi; D Goff
Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma.
Breast cancer research and treatment 1995;36(2):227-36.
1995: D Chatterjee; C J Liu; D Northey; Beverly A Teicher
Molecular characterization of the in vivo alkylating agent resistant murine EMT-6 mammary carcinoma tumors.
Cancer chemotherapy and pharmacology 1995;35(5):423-31.
1995: Beverly A Teicher; Krishna Menon; D Northey; J Liu; Donald Kufe; R Kaddurah-Daouk
Cyclocreatine in cancer chemotherapy.
Cancer chemotherapy and pharmacology 1995;35(5):411-6.
1995: S A Holden; Beverly A Teicher; M F Robinson; D Northey; Andre Rosowsky
Antifolates can potentiate topoisomerase II inhibitors in vitro and in vivo.
Cancer chemotherapy and pharmacology 1995;36(2):165-71.
1995: Beverly A Teicher; N P Dupuis; Y Emi; M Ikebe; Y Kakeji; Krishna Menon
Increased efficacy of chemo- and radio-therapy by a hemoglobin solution in the 9L gliosarcoma.
In vivo (Athens, Greece) 1995;9(1):11-8.
1995: S E Brooks; T T Korbut; N P Dupuis; S A Holden; Beverly A Teicher
Cytotoxicity of antitumor platinum complexes with L-buthionine-(R,S)-sulfoximine and/or etanidazole in human carcinoma cell lines sensitive and resistant to cisplatin.
Cancer chemotherapy and pharmacology 1995;36(5):431-8.
1995: M F Robinson; N P Dupuis; T Kusumoto; F Liu; Krishna Menon; Beverly A Teicher
Increased tumor oxygenation and radiation sensitivity in two rat tumors by a hemoglobin-based, oxygen-carrying preparation.
Artificial cells, blood substitutes, and immobilization biotechnology 1995;23(3):431-8.
1995: N P Dupuis; T Kusumoto; M F Robinson; F Liu; Krishna Menon; Beverly A Teicher
Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
Artificial cells, blood substitutes, and immobilization biotechnology 1995;23(3):423-9.
1995: Beverly A Teicher
An overview on oxygen carriers in cancer therapy.
Artificial cells, blood substitutes, and immobilization biotechnology 1995;23(3):395-405.
1994: S A Holden; Beverly A Teicher; Emil Frei
Long-term persistence and cytokinetics of human tumor cells in vitro following high-dose alkylating agent exposure.
Cancer letters 1994;87(2):211-22.
1994: G Ara; C Norman Coleman; Beverly A Teicher
SR-4233 (Tirapazamine) acts as an uncoupler of oxidative phosphorylation in human MCF-7 breast carcinoma cells.
Cancer letters 1994;85(2):195-203.
1994: Beverly A Teicher; S A Holden; C J Liu; G Ara; T S Herman
Minocycline as a modulator of chemotherapy and hyperthermia in vitro and in vivo.
Cancer letters 1994;82(1):17-25.
1994: Beverly A Teicher; S A Holden; G Ara; E A Sotomayor; Z D Huang; Y N Chen; H Brem
Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents.
International journal of cancer. Journal international du cancer 1994;57(6):920-5.
1994: G Ara; T Kusumoto; T T Korbut; F Cullere-Luengo; Beverly A Teicher
cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement.
Cancer research 1994;54(6):1497-502.
1994: Beverly A Teicher; T T Korbut; Krishna Menon; S A Holden; G Ara
Cyclooxygenase and lipoxygenase inhibitors as modulators of cancer therapies.
Cancer chemotherapy and pharmacology 1994;33(6):515-22.
1994: Beverly A Teicher; N P Dupuis; M F Robinson; T Kusumoto; M Liu; Krishna Menon
Reduced oxygenation in a rat mammary carcinoma post-radiation and reoxygenation with a perflubron emulsion/carbogen breathing.
In vivo (Athens, Greece) 1994;8(1):125-31.
1994: Beverly A Teicher; Joel L. Schwartz; S A Holden; G Ara; D Northey
In vivo modulation of several anticancer agents by beta-carotene.
Cancer chemotherapy and pharmacology 1994;34(3):235-41.
1994: Beverly A Teicher; S A Holden; N P Dupuis; T Kusomoto; M Liu; F Liu; Krishna Menon
Oxygenation of the rat 9L gliosarcoma and the rat 13672 mammary carcinoma with various doses of a hemoglobin solution.
Artificial cells, blood substitutes, and immobilization biotechnology 1994;22(3):827-33.
1994: Beverly A Teicher; E A Sotomayor; N P Dupuis; T Kusumoto; Krishna Menon
Reduced oxygenation in a rat mammary carcinoma after chemo- or radiation therapy and reoxygenation with perflubron emulsion/carbogen breathing.
Journal of cancer research and clinical oncology 1994;120(10):593-8.
1994: Beverly A Teicher; S A Holden; Y N Chen; G Ara; T T Korbut; D Northey
CAI: effects on cytotoxic therapies in vitro and in vivo.
Cancer chemotherapy and pharmacology 1994;34(6):515-21.
1994: Beverly A Teicher; G N Schwartz; N P Dupuis; T Kusomoto; M Liu; F Liu; D Northey
Oxygenation of human tumor xenografts in nude mice by a perfluorochemical emulsion and carbogen breathing.
Artificial cells, blood substitutes, and immobilization biotechnology 1994;22(4):1369-75.
1994: Beverly A Teicher
Combination of perfluorochemical emulsions and carbogen breathing with cancer chemotherapy.
Artificial cells, blood substitutes, and immobilization biotechnology 1994;22(4):1109-20.
1994: Beverly A Teicher
Lonidamine: in vitro/in vivo correlations.
European journal of cancer (Oxford, England : 1990) 1994;30A(10):1411-3.
1993: Beverly A Teicher; S A Holden; G Ara; D Northey
Response of the FSaII fibrosarcoma to antiangiogenic modulators plus cytotoxic agents.
Anticancer research 1993;13(6A):2101-6.
1993: Beverly A Teicher; S D Liu; J T Liu; S A Holden; T S Herman
A carbonic anhydrase inhibitor as a potential modulator of cancer therapies.
Anticancer research 1993;13(5A):1549-56.
1993: Joseph P Eder; V T Chan; E Niemierko; Beverly A Teicher; Lowell E Schnipper
Conditional expression of wild-type topoisomerase II complements a mutant enzyme in mammalian cells.
The Journal of biological chemistry 1993;268(19):13844-9.
1993: Z D Huang; Y N Chen; Krishna Menon; Beverly A Teicher
Synthesis and evaluation of the antitumor activity of 4,5-diamino-substituted 1,2-benzoquinones.
Journal of medicinal chemistry 1993;36(13):1797-801.
1993: Beverly A Teicher; S A Holden; D Northey; Mark Dewhirst; T S Herman
Therapeutic effect of infused Fluosol-DA/carbogen with ephedrine, flunarizine, or nitroprusside.
International journal of radiation oncology, biology, physics 1993;26(1):103-9.
1993: R E Boscia; T Korbut; S A Holden; G Ara; Beverly A Teicher
Interaction of topoisomerase I inhibitors with radiation in cis-diamminedichloroplatinum(II)-sensitive and -resistant cells in vitro and in the FSAIIC fibrosarcoma in vivo.
International journal of cancer. Journal international du cancer 1993;53(1):118-23.
1993: Beverly A Teicher; S A Holden; V Khandakar; T S Herman
Addition of a topoisomerase I inhibitor to trimodality therapy [cis-diamminedichloroplatinum(II)/heat/radiation] in a murine tumor.
Journal of cancer research and clinical oncology 1993;119(11):645-51.
1993: Beverly A Teicher; D Chatterjee; J T Liu; S A Holden; G Ara
Protection of bone-marrow granulocyte-macrophage colony-forming units in mice bearing in vivo alkylating-agent-resistant EMT-6 tumors.
Cancer chemotherapy and pharmacology 1993;32(4):315-9.
1993: Beverly A Teicher; G N Schwartz; E Alvarez Sotomayor; M F Robinson; N P Dupuis; Krishna Menon
Oxygenation of tumors by a hemoglobin solution.
Journal of cancer research and clinical oncology 1993;120(1-2):85-90.
1993: Beverly A Teicher; E A Sotomayor; Z D Huang; G Ara; S Holden; V Khandekar; Y N Chen
beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma.
Cancer chemotherapy and pharmacology 1993;33(3):229-38.
1993: Beverly A Teicher; S A Holden; Krishna Menon; R E Hopkins; M S Gawryl
Effect of hemoglobin solution on the response of intracranial and subcutaneous 9L tumors to antitumor alkylating agents.
Cancer chemotherapy and pharmacology 1993;33(1):57-62.
1993: Emil Frei; S A Holden; R Gonin; D J Waxman; Beverly A Teicher
Antitumor alkylating agents: in vitro cross-resistance and collateral sensitivity studies.
Cancer chemotherapy and pharmacology 1993;33(2):113-22.
1993: G N Schwartz; Beverly A Teicher; Joseph P Eder; T Korbut; S A Holden; G Ara; T S Herman
Modulation of antitumor alkylating agents by novobiocin, topotecan, and lonidamine.
Cancer chemotherapy and pharmacology 1993;32(6):455-62.
1992: Beverly A Teicher; E A Sotomayor; Z D Huang
Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease.
Cancer research 1992;52(23):6702-4.
1992: Beverly A Teicher; T S Herman; Krishna Menon; T T Korbut
Whole-body hyperthermia as an adjuvant to treatment with platinum complexes with or without etanidazole in mice bearing the Lewis lung carcinoma or the FSaLL fibrosarcoma.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1992;8(6):783-94.
1992: T S Herman; Beverly A Teicher; A Varshney; V Khandekar; T Brann
Effect of hypoxia and acidosis on the cytotoxicity of mitoxantrone, bisantrene and amsacrine and their platinum complexes at normal and hyperthermic temperatures.
Anticancer research 1992;12(3):827-36.
1992: J Tanaka; S A Holden; T S Herman; Beverly A Teicher
Response of subpopulations of the FSall C fibrosarcoma to low dose x-rays and various potential enhancing agents.
Anticancer research 1992;12(3):1029-33.
1992: G Ara; A Varshney; Chul Ha; A R Oseroff; T S Herman; Beverly A Teicher
Multiple modality treatment of carcinoma cells with Pt(Rh-123)2 plus x-ray plus light.
Photochemistry and photobiology 1992;55(4):561-7.
1992: S A Holden; Beverly A Teicher; G Ara; T S Herman; C Norman Coleman
Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma.
Journal of the National Cancer Institute 1992;84(3):187-93.
1992: Beverly A Teicher; T S Herman; R E Hopkins; Krishna Menon
Effect of a bovine hemoglobin preparation on the response of the FSaIIC fibrosarcoma to chemotherapeutic alkylating agents.
Journal of cancer research and clinical oncology 1992;118(2):123-8.
1992: Karen Antman; Lois Jeanne Ayash; A Elias; C Wheeler; M Hunt; Joseph P Eder; Beverly A Teicher; J Critchlow; J Bibbo; Lowell E Schnipper
A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(1):102-10.
1992: Beverly A Teicher; S A Holden; G Ara; Chul Ha; T S Herman; D Northey
A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents.
Journal of cancer research and clinical oncology 1992;118(7):509-14.
1992: R Epelbaum; Beverly A Teicher; S A Holden; G Ara; A Varshney; T S Herman
Interaction of D,L- and D-tetraplatin with hyperthermia in vitro and in vivo.
European journal of cancer (Oxford, England : 1990) 1992;28A(4-5):794-800.
1992: E A Sotomayor; Beverly A Teicher; G N Schwartz; S A Holden; Krishna Menon; T S Herman; Emil Frei
Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo.
Cancer chemotherapy and pharmacology 1992;30(5):377-84.
1992: Beverly A Teicher; T S Herman; Krishna Menon
Enhancement of fractionated radiation therapy by an experimental concentrated perflubron emulsion (Oxygent) in the Lewis lung carcinoma.
Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology 1992;20(2-4):899-902.
1992: S A Holden; Beverly A Teicher; Chul Ha; G Ara; T S Herman
Enhancement by perflusion emulsion (Oxygent) and carbogen breathing of the tumor growth delay of the FSaIIC fibrosarcoma after treatment with antitumor alkylating agents.
Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology 1992;20(2-4):895-8.
1992: Beverly A Teicher
Use of perfluorochemical emulsions in cancer therapy.
Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology 1992;20(2-4):875-82.
1992: Beverly A Teicher; S A Holden; G Ara; T S Herman; R E Hopkins; Krishna Menon
Effect of a bovine hemoglobin preparation (SBHS) on the response of two murine solid tumors to radiation therapy or chemotherapeutic alkylating agents.
Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology 1992;20(2-4):657-60.
1991: Lois Jeanne Ayash; T Korbut; T S Herman; Beverly A Teicher
Combination of the minor groove-binder U73-975 or the intercalator mitoxantrone with antitumor alkylating agents in MCF-7 or MCF-7/CP cells.
Cancer letters 1991;61(1):7-14.
1991: Beverly A Teicher; S A Holden; M B Rudolph; E A Sotomayor; T S Herman
Effect of environmental conditions (pH, oxygenation and temperature) on the cytotoxicity of flavone acetic acid and its dimethylaminoethyl ester.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1991;7(6):905-15.
1991: T S Herman; Beverly A Teicher; S A Holden
Addition of mitomycin C to cis-diamminedichloroplatinum(II)/hyperthermia/radiation therapy in the FSaIIC fibrosarcoma.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1991;7(6):893-903.
1991: Beverly A Teicher; A Varshney; V Khandekar; T S Herman
Effect of hypoxia and acidosis on the cytotoxicity of six metal(ligand)4(rhodamine-123)2 complexes at normal and hyperthermic temperatures.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1991;7(6):857-68.
1991: Beverly A Teicher; T S Herman; R E Hopkins; Krishna Menon
Effect of oxygen level on the enhancement of tumor response to radiation by perfluorochemical emulsions or a bovine hemoglobin preparation.
International journal of radiation oncology, biology, physics 1991;21(4):969-74.
1991: Beverly A Teicher; M R Pfeffer; E Alvarez Sotomayor; T S Herman
Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiation.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1991;7(5):773-84.
1991: Beverly A Teicher; T S Herman; S A Holden; M B Rudolph
Effect of oxygenation, pH and hyperthermia on RSU-1069 in vitro and in vivo with radiation in the FSaIIC murine fibrosarcoma.
Cancer letters 1991;59(2):109-17.
1991: Beverly A Teicher; S A Holden; T S Herman; R Epelbaum; Arthur B Pardee; Bruce J Dezube
Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo.
Anticancer research 1991;11(4):1555-60.
1991: J Tanaka; Beverly A Teicher; T S Herman; S A Holden; Bruce J Dezube; Emil Frei
Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivo.
International journal of cancer. Journal international du cancer 1991;48(4):631-7.
1991: S A Holden; Beverly A Teicher; T S Herman
Effect of environmental conditions (pH, oxygenation, and temperature) on misonidazole cytotoxicity and radiosensitization in vitro and in vivo in FSaIIC fibrosarcoma.
International journal of radiation oncology, biology, physics 1991;20(5):1031-8.
1991: Beverly A Teicher; S A Holden; T S Herman; Emil Frei
Modulation of alkylating agents by lonidamine in vivo.
Seminars in oncology 1991;18(2 Suppl 4):7-10.
1991: Beverly A Teicher; T S Herman; S A Holden
Effect of pH, oxygenation, and temperature on the cytotoxicity and radiosensitization by etanidazole.
International journal of radiation oncology, biology, physics 1991;20(4):723-31.
1991: Beverly A Teicher; T S Herman; J Tanaka; Joseph P Eder; S A Holden; G Bubley; C Norman Coleman; Emil Frei
Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Cancer research 1991;51(4):1086-91.
1991: Beverly A Teicher; T S Herman; S A Holden; R Epelbaum; S D Liu; Emil Frei
Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.
Cancer research 1991;51(3):780-4.
1991: Beverly A Teicher; S A Holden; T S Herman; E A Sotomayor; V Khandekar; K W Rosbe; T W Brann; T T Korbut; Emil Frei
Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II).
International journal of cancer. Journal international du cancer 1991;47(2):252-60.
1991: Beverly A Teicher; T S Herman; J Tanaka; Bruce J Dezube; Arthur B Pardee; Emil Frei
Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma.
Cancer chemotherapy and pharmacology 1991;28(1):45-50.
1991: Beverly A Teicher; T S Herman; Larry N Shulman; G Bubley; C Norman Coleman; Emil Frei
Combination of etanidazole with cyclophosphamide and platinum complexes.
Cancer chemotherapy and pharmacology 1991;28(3):153-8.
1990: M R Pfeffer; Beverly A Teicher; S A Holden; A al-Achi; T S Herman
The interaction of cisplatin plus etoposide with radiation +/- hyperthermia.
International journal of radiation oncology, biology, physics 1990;19(6):1439-47.
1990: Beverly A Teicher; M J Abrams; K W Rosbe; T S Herman
Cytotoxicity, radiosensitization, antitumor activity, and interaction with hyperthermia of a Co(III) mustard complex.
Cancer research 1990;50(21):6971-5.
1990: Beverly A Teicher; T S Herman; S M Jones
Influence of scheduling, dose, and volume of administration of a perfluorochemical emulsion on tumor response to radiation therapy.
International journal of radiation oncology, biology, physics 1990;19(4):945-51.
1990: T S Herman; Beverly A Teicher; M R Pfeffer; V Khandekar; R M Chapnick; G S Kalick; A Rabow
Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II).
Radiation research 1990;124(1):28-33.
1990: T S Herman; Beverly A Teicher; C Norman Coleman
Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo.
Cancer research 1990;50(16):5055-9.
1990: Beverly A Teicher; J Stemwedel; T S Herman; P K Ghoshal; Andre Rosowsky
1,2-dithiol-3-thione and dithioester analogues: potential radioprotectors.
British journal of cancer 1990;62(1):17-22.
1990: T S Herman; Beverly A Teicher; M R Pfeffer; V S Khandekar; T T Korbut
Interaction with hyperthermia of tetrachloroplatinum(II)(Nile blue)2 and tetrachloroplatinum(II)(neutral red)2 in EMT6 murine cells and the murine FSaIIC fibrosarcoma.
Cancer research 1990;50(13):3826-31.
1990: Joseph P Eder; A Elias; Thomas C Shea; S M Schryber; Beverly A Teicher; M Hunt; J Burke; R Siegel; Lowell E Schnipper; Emil Frei
A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(7):1239-45.
1990: Beverly A Teicher; S A Holden; A al-Achi; T S Herman
Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma.
Cancer research 1990;50(11):3339-44.
1990: T S Herman; Beverly A Teicher; M R Pfeffer; V S Khandekar
Interaction with hyperthermia of platinum complexes of triaminotriphenylmethane dyes.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1990;6(3):629-39.
1990: T S Herman; Beverly A Teicher; S A Holden; M R Pfeffer; S M Jones
Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma.
Cancer research 1990;50(9):2734-40.
1990: S A Holden; T S Herman; Beverly A Teicher
Addition of a hypoxic cell selective cytotoxic agent (mitomycin C or porfiromycin) to Fluosol-DA/carbogen/radiation.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1990;18(1):59-70.
1990: Beverly A Teicher; T S Herman; S A Holden; Y Y Wang; M R Pfeffer; J W Crawford; Emil Frei
Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo.
Science (New York, N.Y.) 1990;247(4949 Pt 1):1457-61.
1990: Beverly A Teicher; T S Herman; M E Kaufmann
Cytotoxicity, radiosensitization, and DNA interaction of platinum complexes of thiazin and xanthene dyes.
Radiation research 1990;121(2):187-95.
1990: Karen Antman; Joseph P Eder; A Elias; Lois Jeanne Ayash; Thomas C Shea; L Weissman; J Critchlow; S M Schryber; Colin B Begg; Beverly A Teicher
High-dose thiotepa alone and in combination regimens with bone marrow support.
Seminars in oncology 1990;17(1 Suppl 3):33-8.
1990: Beverly A Teicher; S A Holden; Joseph P Eder; T S Herman; Karen Antman; Emil Frei
Preclinical studies relating to the use of thiotepa in the high-dose setting alone and in combination.
Seminars in oncology 1990;17(1 Suppl 3):18-32.
1990: T S Herman; Beverly A Teicher; S A Holden
Trimodality therapy (drug/hyperthermia/radiation) with BCNU or mitomycin C.
International journal of radiation oncology, biology, physics 1990;18(2):375-82.
1990: T S Herman; Beverly A Teicher; M R Pfeffer; V S Khandekar; E Alvarez Sotomayor
Interaction of platinum complexes of thiazin and xanthene dyes with hyperthermia.
Cancer chemotherapy and pharmacology 1990;26(2):127-34.
1990: Joseph P Eder; Beverly A Teicher; S A Holden; L Senator; K N Cathcart; Lowell E Schnipper
Ability of four potential topoisomerase II inhibitors to enhance the cytotoxicity of cis-diamminedichloroplatinum (II) in Chinese hamster ovary cells and in an epipodophyllotoxin-resistant subline.
Cancer chemotherapy and pharmacology 1990;26(6):423-8.
1989: Beverly A Teicher; T S Herman; M R Pfeffer; E Alvarez Sotomayor; V S Khandekar
Interaction of PtCl4(Fast Black)2 with hyperthermia.
Cancer research 1989;49(22):6208-13.
1989: Y Y Wang; Beverly A Teicher; Thomas C Shea; S A Holden; K W Rosbe; A al-Achi; W D Henner
Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
Cancer research 1989;49(22):6185-92.
1989: Beverly A Teicher; S A Holden; Joseph P Eder; T W Brann; S M Jones; Emil Frei
Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo.
Cancer research 1989;49(21):5994-8.
1989: Beverly A Teicher; T S Herman; M E Kaufmann
DNA interaction, cytotoxicity, and radiosensitization with PtCl4(Nile Blue)2 and PtCl4(Neutral Red)2.
Radiation research 1989;120(1):129-39.
1989: Beverly A Teicher; T S Herman; M Kaufmann
Platinum complexes of triaminotriphenylmethanes: interaction with DNA and radiosensitization.
Cancer letters 1989;47(3):217-28.
1989: Beverly A Teicher; D J Waxman; S A Holden; Y Y Wang; L Clarke; E Alvarez Sotomayor; S M Jones; Emil Frei
Evidence for enzymatic activation and oxygen involvement in cytotoxicity and antitumor activity of N,N',N''-triethylenethiophosphoramide.
Cancer research 1989;49(18):4996-5001.
1989: Beverly A Teicher; T S Herman; M E Kaufmann
Interaction of platinum(II) tetrachlorodianion (Fast Black)2 with superhelical DNA and with radiation in vitro and in vivo.
Radiation research 1989;119(1):134-44.
1989: Beverly A Teicher; T S Herman; S A Holden; S M Jones
Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation.
Journal of the National Cancer Institute 1989;81(12):929-34.
1989: T S Herman; Beverly A Teicher; S A Holden; L S Collins
Interaction of hyperthermia and radiation in murine cells: hypoxia and acidosis in vitro, tumor subpopulations in vivo.
Cancer research 1989;49(12):3338-43.
1989: Beverly A Teicher; T S Herman; S M Jones
Optimization of perfluorochemical levels with radiation therapy in mice.
Cancer research 1989;49(10):2693-7.
1989: Y Wang; T S Herman; Beverly A Teicher
Platinum-dye complexes inhibit repair of potentially lethal damage following bleomycin treatment.
British journal of cancer 1989;59(5):722-6.
1989: Emil Frei; Karen Antman; Beverly A Teicher; P Eder; Lowell E Schnipper
Bone marrow autotransplantation for solid tumors--prospects.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(4):515-26.
1989: Joseph P Eder; Beverly A Teicher; S A Holden; K N Cathcart; Lowell E Schnipper; Emil Frei
Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents.
Cancer research 1989;49(3):595-8.
1989: T S Herman; Beverly A Teicher; V Chan; L S Collins; M J Abrams
Effect of heat on the cytotoxicity and interaction with DNA of a series of platinum complexes.
International journal of radiation oncology, biology, physics 1989;16(2):443-9.
1989: K W Rosbe; T W Brann; S A Holden; Beverly A Teicher; Emil Frei
Effect of lonidamine on the cytotoxicity of four alkylating agents in vitro.
Cancer chemotherapy and pharmacology 1989;25(1):32-6.
1989: Beverly A Teicher; S A Holden; S M Jones; Joseph P Eder; T S Herman
Influence of scheduling on two-drug combinations of alkylating agents in vivo.
Cancer chemotherapy and pharmacology 1989;25(3):161-6.
1988: V Chan; K E Elliott; T S Herman; Beverly A Teicher
Alphoid DNA nucleotide sequences from two human cell lines and the corresponding cis-diamminedichloroplatinum(II)-resistant sublines.
Cancer letters 1988;43(3):219-25.
1988: Emil Frei; Beverly A Teicher; S A Holden; K N Cathcart; Y Y Wang
Preclinical studies and clinical correlation of the effect of alkylating dose.
Cancer research 1988;48(22):6417-23.
1988: Beverly A Teicher; T S Herman; S A Holden
Combined modality therapy with bleomycin, hyperthermia, and radiation.
Cancer research 1988;48(22):6291-7.
1988: Beverly A Teicher; T S Herman; C M Rose
Effect of Fluosol-DA on the response of intracranial 9L tumors to X rays and BCNU.
International journal of radiation oncology, biology, physics 1988;15(5):1187-92.
1988: Joseph P Eder; Karen Antman; A Elias; Thomas C Shea; Beverly A Teicher; W D Henner; S M Schryber; S Holden; R Finberg; J Chritchlow
Cyclophosphamide and thiotepa with autologous bone marrow transplantation in patients with solid tumors.
Journal of the National Cancer Institute 1988;80(15):1221-6.
1988: Beverly A Teicher; J M Crawford; S A Holden; Y Lin; K N Cathcart; C A Luchette; J Flatow
Glutathione monoethyl ester can selectively protect liver from high dose BCNU or cyclophosphamide.
Cancer 1988;62(7):1275-81.
1988: T S Herman; Beverly A Teicher; K N Cathcart; M E Kaufmann; J B Lee; M H Lee
Effect of hyperthermia on cis-diamminedichloroplatinum(II) (rhodamine 123)2[tetrachloroplatinum(II)] in a human squamous cell carcinoma line and a cis-diamminedichloroplatinum(II)-resistant subline.
Cancer research 1988;48(18):5101-5.
1988: Beverly A Teicher; S A Holden; K N Cathcart; T S Herman
Effect of various oxygenation conditions and fluosol-DA on cytotoxicity and antitumor activity of bleomycin in mice.
Journal of the National Cancer Institute 1988;80(8):599-603.
1988: Beverly A Teicher; S A Holden; J M Crawford
Effects of Fluosol-DA and oxygen breathing on adriamycin antitumor activity and cardiac toxicity in mice.
Cancer 1988;61(11):2196-201.
1988: T S Herman; Beverly A Teicher
Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma.
Cancer research 1988;48(10):2693-7.
1988: Beverly A Teicher; Emil Frei
Development of alkylating agent-resistant human tumor cell lines.
Cancer chemotherapy and pharmacology 1988;21(4):292-8.
1988: Beverly A Teicher; J L Jacobs; M J Kelley
The influence of Fluosol-DA on the occurrence of lung metastases in Lewis lung carcinoma and B16 melanoma.
Invasion & metastasis 1988;8(1):45-56.
1988: Beverly A Teicher; T S Herman; S A Holden; K N Cathcart
The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo.
Cancer chemotherapy and pharmacology 1988;21(4):286-91.
1988: Beverly A Teicher; S D Bernal; S A Holden; K N Cathcart
Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.
Cancer chemotherapy and pharmacology 1988;21(4):281-5.
1988: Beverly A Teicher; S A Holden; C A Cucchi; K N Cathcart; T T Korbut; J L Flatow; Emil Frei
Combination of N,N',N"-triethylenethiophosphoramide and cyclophosphamide in vitro and in vivo.
Cancer research 1988;48(1):94-100.
1988: Beverly A Teicher; N L McIntosh-Lowe; C M Rose
Effect of various oxygenation conditions and fluosol-DA on cancer chemotherapeutic agents.
Biomaterials, artificial cells, and artificial organs 1988;16(1-3):533-46.
1987: Andre Rosowsky; J E Wright; C A Cucchi; J L Flatow; D H Trites; Beverly A Teicher; Emil Frei
Collateral methotrexate resistance in cultured human head and neck carcinoma cells selected for resistance to cis-diamminedichloroplatinum(II).
Cancer research 1987;47(22):5913-8.
1987: Beverly A Teicher; J M Crawford; S A Holden; K N Cathcart
Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity.
Cancer research 1987;47(19):5036-41.
1987: Beverly A Teicher; S A Holden; K N Cathcart
Efficacy of Pt(Rh-123)2 as a radiosensitizer with fractionated X rays.
International journal of radiation oncology, biology, physics 1987;13(8):1217-24.
1987: Joseph P Eder; Beverly A Teicher; S A Holden; K N Cathcart; Lowell E Schnipper
Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine model.
The Journal of clinical investigation 1987;79(5):1524-8.
1987: Beverly A Teicher; S A Holden; M J Kelley; Thomas C Shea; C A Cucchi; Andre Rosowsky; W D Henner; Emil Frei
Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).
Cancer research 1987;47(2):388-93.
1986: Beverly A Teicher; C A Cucchi; J B Lee; J L Flatow; Andre Rosowsky; Emil Frei
Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
Cancer research 1986;46(9):4379-83.